Skip to content
September 26, 2023
Blogolu

Blogolu

A Directory of Wonderful Things

Primary Menu Blogolu

Blogolu

  • Health and Fitness
  • Newsbeat
  • Compliance
  • Business
  • Food
  • Photography
  • WordPress
  • World
  • Questions & Answer

Does the HIPAA Privacy Rule’s public health provision permit covered entities to disclose protected health information without authorization to a manufacturer of a product regulated by the Food and Drug Administration (FDA) for use by the manufacturer to assess the effectiveness of its marketing campaign?

909 viewsOctober 10, 2022Hospital and Healthcare
0
Sam Smith11.38K December 30, 2020 0 Comments

1 Answer

  • Active
  • Voted
  • Newest
  • Oldest
0
Blogolu28.38K Posted December 30, 2020 0 Comments

No. The public health provision is intended to facilitate the flow of information that is essential to the FDA’s public health mission. The provision does not permit covered entities to disclose protected health information to a manufacturer for the manufacturer’s commercial purposes, or for any other non-public health purpose.

For example, the Rule does not permit a covered entity to provide a drug manufacturer with a list of persons who prefer a different flavored cough syrup over the flavor of the manufacturer’s product. Rather, this provision permits covered entities to disclose protected health information as necessary to continue current voluntary reporting of adverse events and similar reports that are necessary to ensure the quality, safety, or effectiveness of an FDA-regulated product.

For instance, a covered entity would be permitted to report a concern to a drug manufacturer that its cough syrup might be unsafe based on the belief that a difference in the taste could be due to drug tampering or a manufacturing problem. Likewise, a covered health care provider would be permitted to disclose protected health information to a drug manufacturer to report that the failure of a patient’s medical condition to improve may be due to the drug’s ineffectiveness. In making such a report, the covered entity may disclose the protected health information that is reasonably necessary to achieve the purpose of the report.

You are viewing 1 out of 1 answers, click here to view all answers.
Register or Login

Other Categories

  • Art and Design
  • Blogolu
  • Book and Writing
  • Business
  • Compliance
  • Cricket
  • Entertainment
  • Fashion and Beauty
  • FDA
  • Finance
  • Food
  • Graphic Design
  • Health and Fitness
  • Home Services
  • ISO
  • ISO 2768
  • Lifestyle
  • Medical Devices
  • Newsbeat
  • OSHA
  • Photography
  • Science
  • Smart Phones
  • Stories
  • Tech
  • Travel
  • USA
  • WordPress
  • World
  • Latest
  • Popular
  • Trending
    • Finance

    Demystifying Sarbanes-Oxley Act (SOX: A Guide to Financial Transparency and Corporate Accountability

    Blogolu September 19, 2023 0
    • ISO

    ISO 13485:2016 – Ensuring Quality in Medical Device Manufacturing

    Blogolu September 18, 2023 0
    • Medical Devices

    Innovations in Medical Devices: Shaping the Future of Healthcare

    Blogolu September 17, 2023 0
    • FDA

    Navigating FDA Inspections: A Guide to Ensuring Compliance and Success

    Blogolu September 16, 2023 0
    • ISO 2768

    Understanding ISO 2768: The Standard for General Tolerances in Manufacturing

    Blogolu September 15, 2023 0
    • Finance

    Demystifying Sarbanes-Oxley Act (SOX: A Guide to Financial Transparency and Corporate Accountability

    Blogolu September 19, 2023 0
    • Health and Fitness
    • Newsbeat
    • Stories

    America’s abortion ban will effect women everywhere

    Sam Smith July 20, 2022 0
    • Health and Fitness

    Everything you need to know about BEDOYECTA TRI (HYDROXOCOBALAMIN, VITAMIN B1, VITAMIN B6)

    Sam Smith July 20, 2022 0
    • Book and Writing

    How to Write a Book – Beginners Guide

    Sam Smith July 20, 2022 0
    • Photography

    Tips for Capturing the Night Sky with Your Smartphone

    Sam Smith July 20, 2022 0
    • Finance

    Demystifying Sarbanes-Oxley Act (SOX: A Guide to Financial Transparency and Corporate Accountability

    Blogolu September 19, 2023 0
    • ISO

    ISO 13485:2016 – Ensuring Quality in Medical Device Manufacturing

    Blogolu September 18, 2023 0
    • Medical Devices

    Innovations in Medical Devices: Shaping the Future of Healthcare

    Blogolu September 17, 2023 0
    • FDA

    Navigating FDA Inspections: A Guide to Ensuring Compliance and Success

    Blogolu September 16, 2023 0
    • ISO 2768

    Understanding ISO 2768: The Standard for General Tolerances in Manufacturing

    Blogolu September 15, 2023 0

You may have missed

  • Finance

Demystifying Sarbanes-Oxley Act (SOX: A Guide to Financial Transparency and Corporate Accountability

Blogolu September 19, 2023 0
  • ISO

ISO 13485:2016 – Ensuring Quality in Medical Device Manufacturing

Blogolu September 18, 2023 0
  • Medical Devices

Innovations in Medical Devices: Shaping the Future of Healthcare

Blogolu September 17, 2023 0
  • FDA

Navigating FDA Inspections: A Guide to Ensuring Compliance and Success

Blogolu September 16, 2023 0
  • ISO 2768

Understanding ISO 2768: The Standard for General Tolerances in Manufacturing

Blogolu September 15, 2023 0

Blogolu

Blogolu is a bloging platform designed not only to inform readers, but to give complete information visibility of the topic and, ultimately, to push readers towards researched content of products, services, place or a thing. Blogolu blog post can vary in length but is usually design to provide complete information on any topic.

Trending Topics

Art and Design Blogolu Book and Writing Business Compliance Cricket Entertainment Fashion and Beauty FDA Finance Food Graphic Design Health and Fitness Home Services ISO ISO 2768 Lifestyle Medical Devices Newsbeat OSHA Photography Science Smart Phones Stories Tech Travel USA WordPress World
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
  • YouTube
Blogolu © All rights reserved |